Previous 10 | Next 10 |
home / stock / cansf / cansf news
(NewsDirect) Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to share news the company has embarked on a major strategic shift, focusing its commercial efforts on the BioOxi platform. To assist in this transition, Willow Biosciences has engaged an advisor to expl...
WILLOW BIOSCIENCES ANNOUNCES COMMERCIAL TRANSITION AND FOCUS ON BIOOXI PLATFORM Canada NewsWire Announces commercial focus on BioOxi TM bio-oxidation platform as part of targeted alignment on nearer-term and larger revenue opportunities Reduces number of board memb...
2023-08-21 07:47:35 ET For further details see: Willow announces collaboration to develop sustainable intermediates and active pharmaceutical ingredients
WILLOW ANNOUNCES COLLABORATION WITH A LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS Canada NewsWire SUNNYVALE, Calif. , Aug. 21, 2023 /CNW/ - Willow Biosciences Inc. (" Willow ") (TSX:&...
WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS Canada NewsWire New partnerships and contracts expected to bring in over $1 million in near-term R&D/milestone revenue and generate long term commercial revenue SUNNYVALE, Calif. , A...
WILLOW AND KALSEC ADVANCE DEVELOPMENT PROGRAM FOR NEW NATURAL FUNCTIONAL INGREDIENT FOR SAVORY FOODS Canada NewsWire Program further validates Willow's technology and focus on commercial execution and aligns with its strategic focus on near term revenue generation KA...
(NewsDirect) Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to share news the company has agreed to a Master Services Agreement with an innovative biotech company with the focus on age-related diseases. This partnership will see the company develop precision fer...
WILLOW SIGNS MASTER SERVICES AGREEMENT WITH INNOVATIVE BIOTECH COMPANY TO DEVELOP INGREDIENTS FOR AGE-RELATED DISEASES Canada NewsWire Biotech partner recognizes strength of Willow's first in class FutureGrown ™ technology platform for producing natural products ...
KALSEC AND WILLOW BIOSCIENCES TO DEVELOP NOVEL ENZYME FOR PRODUCTION OF AN ADVANCED BEVERAGE INGREDIENT Canada NewsWire Rapid success of first collaboration leads to partnership on high-value specialty ingredient Enzyme development expected to enable commercial-scale p...
WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTS Canada NewsWire MOUNTAIN VIEW, Calif. , May 12, 2023 /CNW/ - Willow Biosciences Inc. (" Willow " or the " Company ") (TSX: WLLW) (OTCQB: CANSF) is pleased to announce...
News, Short Squeeze, Breakout and More Instantly...
Makena Resources Inc Company Name:
CANSF Stock Symbol:
OTCMKTS Market:
WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Canada NewsWire Company continues to advance its corticosteroid production platform and anticipates signing a large strategic partnership in Q2 2024 Signed two new program agr...
Willow Biosciences Inc., (OTC: CANSF) a frontrunner in biotech innovations for sustainable ingredient production, reported its financial and o...
WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF Canada NewsWire Completed the reorganization of the Company during 2023 with all lab operations now located in the Sunnyvale, California Record...